Loading...
Loading...
Exact Sciences Corp.
EXAS today announced that it has expanded its collaboration and license agreement with Mayo Clinic.
Under an extension of the agreement Exact and Mayo Clinic announced in mid-2009, the company's research and development collaboration with David A. Ahlquist, M.D., and his lab will be expanded to include all gastrointestinal cancers and diseases, and new cancer screening applications of stool- and blood-based testing. Exact will continue to have exclusive rights to commercialize breakthroughs that result from this collaboration.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in